CVE-2026-94016 SourceCodester CVE debrief

Who should care

Defenders responsible for the SourceCodester Drug Recommendation System 1.0 should assess their exposure and prioritize verification of the vulnerability's presence in their inventory.

Why it matters

CVE-2026-94016 is a cross-site scripting vulnerability in the SourceCodester Drug Recommendation System 1.0. Defenders should prioritize verifying the presence of this vulnerability in their inventory and assessing the potential impact on their systems.

• Defenders need to verify the presence of this vulnerability in their inventory
• Assess the potential impact on systems using the SourceCodester Drug Recommendation System 1.0
• Consider implementing compensating controls to mitigate the vulnerability

Technical summary

The vulnerability is located in the /drug_recommender/Admin/add_symptom file of the SourceCodester Drug Recommendation System 1.0. An attacker can manipulate the txtname argument to inject malicious code, potentially leading to cross-site scripting attacks. The exploit has been released to the public and may be used for attacks. Remote exploitation of the attack is possible. Defenders should prioritize verifying the presence of this vulnerability in their inventory and assessing the potential impact on their systems.

Defensive priority

Defenders should prioritize verifying the presence of this vulnerability in their inventory and assessing the potential impact on their systems.

Recommended defensive actions

• Verify the presence of this vulnerability in your inventory
• Assess the potential impact on your systems
• Consider implementing compensating controls to mitigate the vulnerability
• Review the supplied official advisory or CVE record to validate affected scope, severity, and vendor guidance
• Plan vendor-supported updates or mitigations through normal change control where exposure is confirmed
• Check relevant monitoring, detection, and logs for exposed assets that need extra review
• Track exceptions, retest remediated assets, and close the item only after evidence is documented

Evidence notes

The CVE record and NVD entry provide limited information about the vulnerability. Further verification is required to determine the affected versions and potential impact. The vulnerability is located in the /drug_recommender/Admin/add_symptom file of the SourceCodester Drug Recommendation System 1.0. An attacker can manipulate the txtname argument to inject malicious code. The exploit has been released to the public and may be used for attacks. Defenders need to verify the presence of this vulnerability in their inventory and assess

Sources and references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.